-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - Inclusion and Exclusion Criteria from Original
Systematic Review
Citations at the abstract review stage … Articles could be excluded at this stage, in hierarchical order, for
the following reasons: not a study … Abstracts from relevant literature are included at the end of the attached document. … Abstracts are provided for included literature at the end of the document. … =ejection fraction; CHD=coronary heart disease; RR=relative risk; CAD=coronary artery disease; ESRD=end-stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - ” or “extensive stage” disease
with the following definitions:
o Limited stage disease (LD): Cancer … o Extensive stage disease (ED): Cancer that cannot be classified as limited
stage, such as when there … In
addition, some patients cannot receive iodinated contrast material due to renal
insufficiency, limiting … previously noted, performance
of various imaging modalities may be impacted by comorbidities such renal … Because of their role as
end-users, individuals are invited to serve as Key Informants and those who
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - -
stage renal disease (on dialysis or choosing not to have dialysis and age 75 or older), and those with … These include
advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage renal … These include advanced heart failure, advanced chronic obstructive pulmonary disease, end-stage
renal … Evidence for improving palliative care at the end of life: a
systematic review. … Populations and Interventions for Palliative and End-of-
Life Care: A Systematic Review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
March 01, 2013 - Two
reviewers evaluated each study at the title or abstract stage
and at the full text article stage … emergency room visits or
hospitalizations for treatment of recurrent stones, quality
of life, and end-stage … renal disease. … emergency room treatment and/or hospitalization
related to stone recurrence, quality of life, and/or end-stage … renal disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - accounting for
almost 60% of all organ transplants.1 Kidney transplantation is the treatment of choice for end … stage renal disease. … Key Informants
Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who … graft
dysfunction'/exp OR 'renal graft dysfunction' OR (kidney OR renal) NEAR/2
(allograft* OR alograft
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - shares similar risk factors: male gender, age,
diabetes, smoking, hypertension, high cholesterol, and renal … Fontaine classification
Stage I No symptoms
Stage IIa Intermittent claudication > 200m of walking … Stage 3 Rest pain
Stage 4 Necrosis/gangrene
Table 2. … Rutherford classification
Stage 0 Asymptomatic
Stage 1 Mild claudication
Stage 2 Moderate claudication … Stage 3 Severe claudication
Stage 4 Rest pain
Stage 5 Ischemic ulceration not exceeding ulcer of
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - High-Impact Potential: Lower end of the high-impact-potential range
Gout
Gout is the most prevalent … High-Impact Potential: Lower end of the high-impact-potential range
Psoriatic Arthritis
Psoriatic … High-Impact Potential: Lower end of the high-impact-potential range
1
Ankylosing Spondylitis … organic anion transporter involved in
controlling the reabsorption of uric acid from the proximal renal … However, better gout management could reduce hospitalizations and renal or
cardiovascular complications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
May 01, 2013 - race/
ethnicity, socioeconomic status, and diverse specific
medical comorbidities (e.g., diabetes, end-stage … renal
disease, dementia), many Key Informants suggested that
we include specific known risk factors … race/ethnicity, socioeconomic status, and diverse specific
medical comorbidities (e.g., diabetes, end-stage … renal
disease, and dementia), as well as patients with specific
known risk factors for pressure ulcers … Stage I is
defined as superficial erythema, stage II as partial thickness
ulceration, stage III as
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - Adjunct for the prevention of rejection in renal
homotransplantation; management of active
rheumatoid … (Hoffmann-La
Roche)
Prophylaxis of organ rejection in patients receiving
allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving
allogeneic renal, cardiac, or hepatic transplants … Key Informants
Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - To that end, advances in molecular and genomic medicine, such as gene
expression profiling, may improve … underestimation of the tumor genomic landscape from analysis of multiple samples from patients
with primary renal … 1) and stage
D (Stage IV) colorectal cancer. … A or stage D. … T-stage, N-stage and MSI status.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
February 01, 2011 - Those with diabetes are expected to suffer from several associ-
ated medical complications, such as renal … The prevalence of LEA in
nonelderly diabetics with PAD (many
of whom likely have end-stage renal
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
November 30, 2011 - harms differ according to patient subgroup characteristics, including HCV
genotype, age, race, sex, stage … non-black); sex; stage of disease (e.g., cirrhosis or fibrosis); others (e.g., baseline viral
load, … weight)
Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with
renal … Key Informants
Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users,
individuals are invited to serve as Key Informants and those who
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - amputation
2
People with diabetes often experience sev-
eral associated medical complications,
such as renal … The latter set of ICD-9 codes
represents the following microvascular diseases: diabetic
renal disease … Nontraumatic lower extremity amputations
in the Medicare end-stage renal disease population.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
February 01, 2013 - No
eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … RLS is unknown, but the disorder also occurs secondary to other
conditions such as iron deficiency, end-stage … No eligible studies enrolled individuals with end-stage renal disease, and almost all
specifically excluded … -
Stage Renal Disease Requiring
Hemodialysis
Drug: Rotigotine; Placebo
NCT00258492 RLS Syndrome … Stage Renal Disease And Hemodialysis
On The Pharmacokinetics Of Ropinirole
Drug: ropinirole dosing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - On page 20 lines 5-13, this topic is
finally broached at the end of the "Future Research" section. … We know that CIN incidence varies dramatically based on baseline
renal function, and the absence of … contrast-induced nephropathy (CIN),
for the outcomes of incidence of CIN, chronic
kidney disease (CKD), end … stage renal
disease (ESRD), mortality, and other adverse
events? … Need for renal replacement therapy is
addressed in all comparisons.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
March 15, 2016 - accepted the target serum uric acid (SUA)
levels (as opposed to gout flare reduction) as their primary end-points … We have modified the text on use in renal
impairment. … However, what is the stage before the acute arthritis stage?
Asympotmatic hyperuricemia? … disease, and of intervening upon
hyperuricemia demonstrating renal benefits. … These decisions were
made at the Topic Refinement stage.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
July 01, 2014 - Potential outcome measure by stage .................................................................. … Characteristics associated with ACP at various stages
Stage of Health/Illness
Healthy Potentially … domain: the
interactive CD-ROM,32 the enhanced information aid,25 a Web site intervention in pilot stage … Potential outcome measure by stage
Outcome Stage of Health / Illness
Healthy Potentially Life
Threatening … Paradigm Task Force
Ottawa Patient Decision Aid Research Group
PBS Religion & Ethics Newsweekly
Renal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendices.pdf
January 01, 2025 - impairment, end-stage renal disease, urinary tract
infection, stone-removal procedures/surgery, procedure … stone”[tw] OR “renal stones”[tw] OR “renal
calcul*”[tw] OR “staghorn calculi”[tw] OR “staghorn calculus … " NEXT stone):ti,ab OR ("renal" NEXT stones):ti,ab OR ("renal" NEXT calcul*):ti,ab
OR ("staghorn" NEXT … J
Endourol. 2020 Feb;34(2):139-44. doi:
10.1089/end.2019.0574. PMID: 31663371. … J
Endourol. 2021 Dec;35(12):1844-51. doi:
10.1089/end.2021.0122. PMID: 34254834.
34.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - one of two locations: respiratory tract (lung and head/neck) and genitourinary (bladder, prostate, renal … enrichment was performed using the modified SureSelect Target Enrichment System for Illumina Paired End … sequencing library and enriched using standard hybridization capture conditions, for 150-bp paired-end … (NR) 0.927 (0.907 to 0.946) NA NA NA NA NA NA NA NA NA NA NA NA NA NA None
Ren 2016 Diagnostic CC Renal … Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening:
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - one of two locations: respiratory tract (lung and head/neck) and genitourinary (bladder, prostate, renal … enrichment was performed using the modified SureSelect Target Enrichment System for Illumina Paired End … sequencing library and enriched using standard hybridization capture conditions, for 150-bp paired-end … (NR) 0.927 (0.907 to 0.946) NA NA NA NA NA NA NA NA NA NA NA NA NA NA None
Ren 2016 Diagnostic CC Renal … Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: